Company Cyber Security Posture
NANA
NA Company Details
NA
NA
NA
NA
NA
NA
Scan still pending
NA
NA
NA Risk Score (AI oriented)Between 200 and 800
This score is AI-generated and less favored by cyber insurers, who prefer the TPRM score.
NA Global Score.png)
Company Scoring based on AI Models
| Model Name | Date | Description | Current Score Difference | Score |
|---|---|---|---|---|
| AVERAGE-Industry | 03-12-2025 | This score represents the average cybersecurity rating of companies already scanned within the same industry. It provides a benchmark to compare an individual company's security posture against its industry peers. | N/A | Between 200 and 800 |
Company Cyber Security News & History
| Entity | Type | Severity | Impact | Seen | Url ID | Details | View |
|---|
Company Subsidiaries
NA
Access Data Using Our API
Get company history
Rapid.png)
NA Cyber Security News
Ionis reports positive data from study of olezarsen for hypertriglyceridemia
Ionis reports positive data from study of olezarsen for hypertriglyceridemia · US Tariffs are shifting - will you react or anticipate? Don't let ...
Analysts Just Made A Sizeable Upgrade To Their Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Forecasts
Shareholders in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) may be thrilled to learn that the analysts have just delivered a major upgrade to ...
US FDA approves Ionis Pharma's genetic disorder drug
The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's ...
10 Promising Biotech Stocks to Invest in (June 2025)
Securities.io maintains rigorous editorial standards and may receive compensation from reviewed links. We are not a registered investment ...
Ionis Pharmaceuticals Inc (IONS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Ionis Pharmaceuticals Inc (IONS) reports a 10% revenue increase and raises 2025 guidance, driven by successful product launches and ...
Why the Chamber of Progress is endorsing a permitting bill
CENTER-LEFT TECH GROUP PITCHES POLICY FRAMEWORK: Chamber of Progress, the left-leaning Silicon Valley-funded industry group, is branching out ...
Ionis Pharmaceuticals (IONS) Reports Q1 Earnings: What Key Metrics Have to Say
For the quarter ended March 2025, Ionis Pharmaceuticals (IONS) reported revenue of $132 million, up 10.9% over the same period last year.
Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal
Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Ono Pharmaceutical Co., Ltd entered into a license agreement in which Ono obtains exclusive global rights.
Biogen, Ionis to discontinue development of experimental ALS drug
Biogen and Ionis' drug, BIIB105, did not succeed in significantly reducing neurodegeneration or improving functional measures such as breathing, ...
NA Similar Companies
Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac
Eurofins
Since 1987, Eurofins has grown from one laboratory in Nantes, France to ca. 63,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eval
Amgen
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Gilead Sciences
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
bioMérieux
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v
Biocon
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthc
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
NA CyberSecurity History Information
How many cyber incidents has NA faced?
Total Incidents: According to Rankiteo, NA has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at NA?
Incident Types: The types of cybersecurity incidents that have occurred include .
Additional Questions
What Do We Measure?
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
